These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
615 related articles for article (PubMed ID: 27157296)
1. Clinicopathological categorization of Epstein-Barr virus-positive T/NK-cell lymphoproliferative disease: an analysis of 42 cases with an emphasis on prognostic implications. Paik JH; Choe JY; Kim H; Lee JO; Kang HJ; Shin HY; Lee DS; Heo DS; Kim CW; Cho KH; Kim TM; Jeon YK Leuk Lymphoma; 2017 Jan; 58(1):53-63. PubMed ID: 27157296 [TBL] [Abstract][Full Text] [Related]
2. Spectrum of Epstein-Barr virus-associated T-cell lymphoproliferative disorder in adolescents and young adults in Taiwan. Wang RC; Chang ST; Hsieh YC; Huang WT; Hsu JD; Tseng CE; Wang MC; Hwang WS; Wang J; Chuang SS Int J Clin Exp Pathol; 2014; 7(5):2430-7. PubMed ID: 24966953 [TBL] [Abstract][Full Text] [Related]
3. Clinicopathological categorization of hydroa vacciniforme-like lymphoproliferative disorder: an analysis of prognostic implications and treatment based on 19 cases. Guo N; Chen Y; Wang Y; Huang Y; Feng Y; Li M; Rao H Diagn Pathol; 2019 Jul; 14(1):82. PubMed ID: 31315684 [TBL] [Abstract][Full Text] [Related]
4. Epstein-Barr virus-associated T- and NK-cell lymphoproliferative diseases: an update and diagnostic approach. Hue SS; Oon ML; Wang S; Tan SY; Ng SB Pathology; 2020 Jan; 52(1):111-127. PubMed ID: 31767131 [TBL] [Abstract][Full Text] [Related]
5. Clinicopathological states of Epstein-Barr virus-associated T/NK-cell lymphoproliferative disorders (severe chronic active EBV infection) of children and young adults. Suzuki K; Ohshima K; Karube K; Suzumiya J; Ohga S; Ishihara S; Tamura K; Kikuchi M Int J Oncol; 2004 May; 24(5):1165-74. PubMed ID: 15067338 [TBL] [Abstract][Full Text] [Related]
6. Atypical hydroa vacciniforme-like epstein-barr virus associated T/NK-cell lymphoproliferative disorder. Lee HY; Baek JO; Lee JR; Park SH; Jeon IS; Roh JY Am J Dermatopathol; 2012 Dec; 34(8):e119-24. PubMed ID: 23169419 [TBL] [Abstract][Full Text] [Related]
7. Systemic Epstein-Barr Virus-Positive T/NK Lymphoproliferative Diseases With Ishimura M; Eguchi K; Shiraishi A; Sonoda M; Azuma Y; Yamamoto H; Imadome KI; Ohga S Front Pediatr; 2019; 7():183. PubMed ID: 31231620 [TBL] [Abstract][Full Text] [Related]
9. EBV-associated T/NK-cell lymphoproliferative diseases in nonimmunocompromised hosts: prospective analysis of 108 cases. Kimura H; Ito Y; Kawabe S; Gotoh K; Takahashi Y; Kojima S; Naoe T; Esaki S; Kikuta A; Sawada A; Kawa K; Ohshima K; Nakamura S Blood; 2012 Jan; 119(3):673-86. PubMed ID: 22096243 [TBL] [Abstract][Full Text] [Related]
10. Hydroa vacciniforme: a distinctive form of Epstein-Barr virus-associated T-cell lymphoproliferative disorders. Iwatsuki K; Miyake T; Hirai Y; Yamamoto T Eur J Dermatol; 2019 Feb; 29(1):21-28. PubMed ID: 30998212 [TBL] [Abstract][Full Text] [Related]
11. Proposed categorization of pathological states of EBV-associated T/natural killer-cell lymphoproliferative disorder (LPD) in children and young adults: overlap with chronic active EBV infection and infantile fulminant EBV T-LPD. Ohshima K; Kimura H; Yoshino T; Kim CW; Ko YH; Lee SS; Peh SC; Chan JK; Pathol Int; 2008 Apr; 58(4):209-17. PubMed ID: 18324913 [TBL] [Abstract][Full Text] [Related]
13. Hydroa vacciniforme-like lymphoproliferative disorder: A clinicopathological, immunohistochemical, and prognostic study of 24 cases in China. Wang X; Liang Y; Yang Y; Li W; Wang G; Wang S; Li Y; Zhang M J Dermatol; 2021 Sep; 48(9):1315-1326. PubMed ID: 33982815 [TBL] [Abstract][Full Text] [Related]
14. Somatic mutations in Gao LM; Zhao S; Zhang WY; Wang M; Li HF; Lizaso A; Liu WP Cancer Biol Ther; 2019; 20(10):1319-1327. PubMed ID: 31311407 [TBL] [Abstract][Full Text] [Related]